See also this year's filing and all EDGAR filings for this company.
PDF Report 0001739426_2023_RVL_Pharmaceuticals_plc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001739426, RVL Pharmaceuticals plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 56,975,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 69,747,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 1,788,000 |
| 4 | LiabilitiesCurrent | 19,723,000 |
| 5 | LiabilitiesNoncurrent | 94,000 |
| 6 | remainder_Liabilities | 57,600,000 |
| 7 | CostOfGoodsAndServicesSold | 9,439,602 |
| 8 | SellingGeneralAndAdministrativeExpense | 80,758,273 |
| 9 | ResearchAndDevelopmentExpense | 4,314,069 |
| 10 | remainder_Expenses | 13,010,863 |
| 11 | remainder_Revenues | 49,730,511 |
| 12 | remainder_NetIncome | 11,012,771 |
| 13 | remainder_ComprehensiveNetIncome | 3,915,417 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 128,510,000 |
| 1 | Liabilities | 77,417,000 |
| 2 | Expenses | 107,522,807 |
| 3 | Revenues | 49,730,511 |
| 4 | StockholdersEquity | 51,093,000 |
| 5 | NetIncome | -46,779,525 |
| 6 | ComprehensiveNetIncome | -44,821,816 |
| 7 | BaseVar | 189,054,253 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.646 |
| 9 | EconomicCapitalRatio | 2.01 |
Edgar->Model Mapping
Feature Distribution
Change over Time
